Au, J. K., Graziano, C., Elizondo, R. A., Ryan, S., Roth, D. R., Koh, C. J., . . . Seth, A. (2017). Urologic outcomes of children with hemorrhagic cystitis after bone marrow transplant at a single institution. Urology, 101, 126–162. doi:10.1016/j.urology.2016.10.030 Bakhshi, S., Batra, A., Biswas, B., Dhawan, D., Paul, R. e Sceenivas, V. (2015). Aprepitant as an add-on therapy in children receiving highly emetogenic chemotherapy: A randomized, double-blind, placebo- controlled trial. Supportive Care in Cancer, 23 (11), 3229–3237. doi:10.1007/s00520-015-2714-9 Barber, N. A. e Ganti, A. K. (2011). Pulmonary toxicities from targeted therapies: a review. Targeted Oncology, 6 (4), 235-243. doi:10.1007/ s11523-011-0199-0 Bartholomew, J., Washington, T., Bergeron, S., Nielson, D., Saggio, J. e Quirk, L. (2017). Dinutuximab: A novel immunotherapy in the treatment of pediatric patients with high-risk neuroblastoma. Journal of Pediatric Oncology Nursing, 34 (1), 5-12. doi:10.1177/1043454216659448 Basch, E., Prestrud, A. A., Hesketh, P. J., Kris, M. G., Feyer, P. C., Somerfield, M. R., . . . Lyman, G. H. (2011). Antiemetics: American Society of Clinical Oncology clinical practice guideline update. Journal of Clinical Oncology, 29 (31), 4189–4198. doi:10.1200/ JCO.2010.34.4614 Bass, J. K., Knight, K. R., Yock, T. I., Chang, K. W., Cipkala, D. e Grewal, S. S. (2016). Evaluation and management of hearing loss in survivors of childhood and adolescent cancers: A report from the Children’s Oncology Group. Pediatric Blood and Cancer, 63, 1152–1162. doi:10.1002/pbc.25951 Baxter, A. L., Watcha, M. F., Baxter, W. V., Leong, T. e Wyatt, M. M. (2011). Development and validation of a pictorial nausea rating scale for children. Pediatrics, 127 (6), e1542–1549. doi:10.1542/ peds.2010-1410 Bensinger, W., Schubert, M., Ang, K. K., Brizel, D., Brown, E., Eilers, J., . . . Trotti, A. M. (2008). NCCN task force report: Prevention and management of mucositis in cancer care. Journal of National Comprehensive Cancer Network, 6 (suppl 1), S1–S21. Extraído de: https://www.nccn.org/JNCCN/PDF/mucositis_2008.pdf Bercovitz, R. S. e Josephson, C. D. (2012). Thrombocytopenia and bleeding in pediatric oncology patients. ASH Hematology, The Education Program, 2012, 499–505. doi:10.1182/ asheducation-2012.1.499 Bhave, M., Akhter, N., & Rosen, S. T. (2014). Cardiovascular toxicity of biologic agents for cancer therapy. Oncology (Williston Park), 28 (6), 482–490. Bichet, D. G. (2015). Clinical manifestations and causes of central diabetes insipidus. Em T. W. Post (Ed.), UpToDate . Extraído de: https://www.uptodate.com Braam, K. I., van der Torre, P., Takken, T., Veening, M. A., van Dulmen-den Broeder, E. e Kaspers, G. J. (2013). Physical exercise training interventions for children and young adults during and after treatment for childhood cancer. Cochrane Database of Systematic Reviews, 30 (4). doi:10.1002/14651858.CD008796.pub2 Bradfield, S. M., Sandler, E., Geller, T., Tamura, R. N. e Krischer, J. P. (2015). Glutamic acid not beneficial for the prevention of vincristine neurotoxicity in children with cancer. Pediatric Blood and Cancer, 62 (6), 1004–1010. doi:10.1002/pbc.25384 Breslin, S. (2007). Cytokine-release syndrome: Overview and nursing implications. Clinical Journal of Oncology Nursing, 11 (1 suppl), 37–42. doi:10.1188/07.CJON.S1.37-42 Briasoulis, E. e Pavlidis, N. (2001). Noncardiogenic pulmonary edema: An unusual and serious complication of anticancer therapy. The Oncologist, 6 (2), 153–161. doi:10.1634/theoncologist.6-2-153 Bromley, D. (2014). Abdominal massage in the management of chronic constipation for children with disabilities. Community Practitioner, 87 (12), 25–29.
Referências Abbas, A., Mirza, M. M., Ganti, A. K. e Tendulkar, K. (2015). Renal toxicities of targeted therapies. Targeted Oncology, 10 (4), 487–499. doi:10.1007/s11523-015-0368-7 Abid, S. H., Malhotra, V. e Perry, M. C. (2001). Radiation-induced and chemotherapy-induced pulmonary injury. Current Opinions in Oncology, 13, 242–248. PMID11429 Agrawal, A. K., Chang, P. P. e Feusner, J. (2011). Twice weekly Pneumocystis jiroveci pneumonia prophylaxis with trimethoprim-sulfamethoxazole in pediatric patients with acute lymphoblastic leukemia . Journal of Pediatric Hematology/Oncology, 33 (1), e1–e4. doi:10.1097/MPH.0b013e3181fd6fca Al Jaouni, S. K., Al Muhayawi, M. S., Hussein, A., Elfiki, I., Al-Raddadi, R., Al Muhayawi, S. M., . . . Harakeh, S. (2017). Effects of honey on oral mucositis among pediatric cancer patients undergoing chemo/ radiotherapy treatment at King Abdulaziz University Hospital in Jeddah, Kingdom of Saudi Arabia. Evidence-Based Complementary and Alternative Medicine, 2017, 5861024. doi:10.1155/2017/5861024 Alam, A., Lin, Y., Lima, A., Hansen, M. e Callum, J. L. (2013). The prevention of transfusion-associated circulatory overload. Transfusion Medicine Reviews, 27 (2), 105–112. doi:10.1016/j.tmrv.2013.02.001 Alders, M. e Christiaans, I. (2003, atualizado em 2015). Long QT syndrome. Em M. P. Adam (Ed.), GeneReviews [Internet]. Seattle, WA: University of Washington. Extraído de: https://www.ncbi.nlm.nih. gov/books/NBK1129/ Allen, C. E., Ladisch, S. e McClain, K. L. (2015). How I treat Langerhans cell histiocytosis. Blood, 126 (1), 26–35. doi:10.1182/ blood-2014-12-569301 Allison, R. R., Ambrad, A. A., Arshoun, Y., Carmel, R. J., Ciuba, D. F., Feldman, E., . . . Sonis, S. T. (2014). Multi - institutional, randomized, double - blind, placebo - controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck. Cancer, 120 (9), 1433–1440. doi:10.1002/cncr.28553 Amadori, F., Bardellini, E., Conti, G., Pedrini, N., Schumacher, R. F. e Majorana, A. (2016). Low-level laser therapy for treatment of chemotherapy-induced oral mucositis in childhood: A randomized double-blind controlled study. Lasers in Medical Science, 31 (6), 1231– 1236. doi:10.1007/s10103-016-1975-y Amankwah, E. K., Saenz, A. M., Hale, G. A. e Brown, P. A. (2016). Association between body mass index at diagnosis and pediatric leukemia mortality and relapse: A systematic review and meta- analysis. Leukemia and Lymphoma, 57 (5), 1140–1148. doi: 10.3109/10428194.2015.1076815. American College of Obstetricians and Gynecologists, Committee on Adolescent Health Care. (2014). Primary ovarian insufficiency in adolescents and young women. Extraído de: https://www.acog.org/-/ media/Committee-Opinions/Committee-on-Adolescent- Health-Care/co605.pdf?dmc=1&ts=20160601T2350574110 Ames, B., Lewis, L. D., Chaffee, S., Kim, J. e Morse, R. (2010). Ifosfamide-induced encephalopathy and movement disorder. Pediatric Blood and Cancer, 54 (4), 624–626. doi:10.1002/pbc.22361 Amirana, S. e Babby, J. (2015). A review of drug-induced liver injury. The Journal for Nurse Practitioners, 11 (2), 270–271. doi:10.1016/j. nurpra.2014.11.010 Asselin, B. (2016). Immunology of infusion reactions in the treatment of patients with acute lymphoblastic leukemia. Future Oncology. doi:10.2217/fon-2016-0005 Athale, U. H., Laverdiere, C., Nayiager, T., Delva, Y.-L., Foster, G., Thabane, L. e Chan, A. K. (2017). Evaluation for inherited and acquired prothrombotic defects predisposing to symptomatic thromboembolism in children with acute lymphoblastic leukemia: A protocol for a prospective, observational, cohort study. BMC Cancer, 17 (1), 313. doi:10.1186/s12885-017-3306-5
Capítulo 8. Toxicidade e Tratamento de Sintomas 279
Powered by FlippingBook